Cite
HARVARD Citation
Bolomsky, A. et al. (2020). The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene. British journal of haematology. pp. 877-890. [Online].